#Remdesivir close to EU's initial authorisation as #COVID_19 treatment

4633

Tuesday, 19 May, 2020, 12:05

#Remdesivir close to EU's initial authorisation as #COVID_19 treatment

The head of the European Union's medicines agency Guido Rasi said on Monday an initial authorisation for U.S. pharmaceutical company Gilead's remdesivir as a COVID-19 treatment could be granted in coming days.
The European Medicines Agency (EMA) has already recommended the compassionate use of remdesivir, which allows a drug to be administered to patients even before it has been fully authorised.
"It might be that a conditional market authorisation can be issued in the coming days," Rasi told a hearing in the EU Parliament in Brussels.
Apart from remdesivir, Rasi said other possible treatments against COVID-19 that may be available fast are those based on monoclonal antibodies, which can "neutralize" the new coronavirus (SARS-CoV-2) that causes the illness COVID-19.

Kentron

news agency

#Remdesivir close to EU's initial authorisation as #COVID_19 treatment

Read Also

Gene-edited bananas that don’t go brown could hit UK supermarkets

SpaceX Starship splashes down after reaching orbit in unprecedented test flight

Ancient wall found beneath Paris could confirm site of first settlement

13,000 years ago, you could walk from Sicily to Malta. Now scientists are mapping the lost route

Full-ocean-depth EM124 mapping of the Challenger Deep by R/V Hakuho-maru and depth-estimate sensitivity tests

Scientists perplexed as iconic dinosaur thought unique to America is found in Spain (photo)